RFK Jr's CDC Panel Recommends Merck's RSV Shot For Infants

benzinga.com/news/health-care/25/06/46136734/rfk-jrs-cdc-panel-recommends-mercks-rsv-shot-for-infants

The U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) voted to recommend Merck & Co Inc’s (NYSE:MRK) Enflonsia (clesrovimab-cfor) as an option for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease…

This story appeared on benzinga.com, 2025-06-27 11:56:22.
The Entire Business World on a Single Page. Free to Use →